Id: | acc3678 |
Group: | 1sens |
Protein: | Akt |
Gene Symbol: | Akt1 |
Protein Id: | P47196 |
Protein Name: | AKT1_RAT |
PTM: | phosphorylation |
Site: | Ser473 |
Site Sequence: | ERRPHFPQFSYSASGTA---- |
Disease Category: | Endocrine and metabolic diseases |
Disease: | Obese |
Disease Subtype: | insulin resistance |
Disease Cellline: | |
Disease Info: | |
Drug: | losartan |
Drug Info: | Losartan is an angiotensin II receptor blocker used to treat high blood pressure and reduce the risk of stroke in patients with high blood pressure and an enlarged heart. |
Effect: | modulate |
Effect Info: | Losartan attenuated the reduction of Akt phosphorylation in the hearts of obese rats and alleviated insulin resistance. |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 12960006 |
Sentence Index: | 12960006_8 |
Sentence: | Pretreatment with losartan did not change insulin-induced activation of ERK1/2 and attenuated the reduction of Akt phosphorylation in the heart of obese rats. |
Sequence & Structure:
MNDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVEQRESPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKRQEEETMDFRSGSPSDNSGAEEMEVALAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPTQRLGGGSEDAKEIMQHRFFANIVWQDVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
No data.
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
S | 473 | D | Major depressive disorder | Phosphorylation | 16959794 |
S | 473 | D | Type 2 diabetes | Phosphorylation | 34057658 ;  36374861 |
S | 473 | U | Status epilepticus | Phosphorylation | 35562960 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.